Zurich Cantonal Bank’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.92M Sell
147,227
-12,092
-8% -$806K 0.02% 496
2026
Q1
$10M Buy
+159,319
New +$11.1M 0.02% 491
2025
Q4
Sell
-156,046
Closed -$10.1M 2849
2025
Q3
$10.5M Sell
156,046
-216
-0.1% -$17.1K 0.02% 461
2025
Q2
$13.6M Sell
156,262
-81,597
-34% -$6.4M 0.03% 390
2025
Q1
$16.2M Buy
237,859
+39,211
+20% +$3.2M 0.05% 342
2024
Q4
$15.4M Buy
198,648
+53,158
+37% +$3.94M 0.04% 338
2024
Q3
$9.75M Sell
145,490
-2,251
-2% -$185K 0.03% 445
2024
Q2
$16.8M Buy
147,741
+11,846
+9% +$1.5M 0.05% 293
2024
Q1
$18.8M Buy
135,895
+3,695
+3% +$464K 0.07% 270
2023
Q4
$16.4M Buy
132,200
+46,062
+53% +$4.71M 0.06% 281
2023
Q3
$8.04M Sell
86,138
-81,525
-49% -$9.19M 0.04% 395
2023
Q2
$21.5M Buy
167,663
+66,258
+65% +$8.01M 0.1% 198
2023
Q1
$11.8M Buy
101,405
+25,435
+33% +$2.85M 0.06% 308
2022
Q4
$8.6M Sell
75,970
-3,419
-4% -$375K 0.05% 362
2022
Q3
$6.39M Buy
79,389
+17,242
+28% +$1.46M 0.04% 412
2022
Q2
$4.63M Sell
62,147
-37,541
-38% -$3.43M 0.03% 482
2022
Q1
$12.8M Buy
99,688
+14,640
+17% +$1.6M 0.06% 289
2021
Q4
$11.4M Buy
85,048
+18,564
+28% +$2.67M 0.06% 318
2021
Q3
$9.09M Sell
66,484
-28,984
-30% -$3.66M 0.05% 352
2021
Q2
$10.2M Sell
95,468
-11,696
-11% -$1.12M 0.06% 316
2021
Q1
$9.63M Buy
107,164
+568
+0.5% +$53.3K 0.06% 319
2020
Q4
$9.85M Sell
106,596
-3,384
-3% -$302K 0.06% 309
2020
Q3
$11.3M Buy
109,980
+9,776
+10% +$1.02M 0.08% 222
2020
Q2
$10.2M Buy
100,204
+12,652
+14% +$1.13M 0.09% 228
2020
Q1
$5.89M Buy
87,552
+10,784
+14% +$671K 0.06% 336
2019
Q4
$4.2M Sell
76,768
-5,072
-6% -$241K 0.03% 469
2019
Q3
$3.05M Buy
81,840
+1,796
+2% +$69.8K 0.03% 530
2019
Q2
$3M Hold
80,044
0.03% 534
2019
Q1
$2.38M Buy
80,044
+6,380
+9% +$224K 0.02% 587
2018
Q4
$2.21M Buy
73,664
+50,916
+224% +$1.62M 0.02% 582
2018
Q3
$813K Buy
22,748
+540
+2% +$16.7K 0.01% 825
2018
Q2
$527K Buy
22,208
+1,884
+9% +$39.9K ﹤0.01% 897
2018
Q1
$377K Buy
20,324
+2,140
+12% +$31.6K ﹤0.01% 930
2017
Q4
$261K Sell
18,184
-55,076
-75% -$716K ﹤0.01% 1052
2017
Q3
$896K Hold
73,260
0.01% 794
2017
Q2
$1.34M Hold
73,260
0.01% 729
2017
Q1
$1.55M Hold
73,260
0.02% 700
2016
Q4
$1.09M Buy
73,260
+61,756
+537% +$1.09M 0.01% 765
2016
Q3
$252K Buy
11,504
+3,124
+37% +$69.5K ﹤0.01% 917
2016
Q2
$166K Hold
8,380
﹤0.01% 965
2016
Q1
$142K Hold
8,380
﹤0.01% 985
2015
Q4
$172K Buy
8,380
+4,624
+123% +$96.2K ﹤0.01% 954
2015
Q3
$81K Buy
3,756
+2,544
+210% +$56.8K ﹤0.01% 994
2015
Q2
$24K Hold
1,212
﹤0.01% 1056
2015
Q1
$19K Buy
+1,212
New +$18.3K ﹤0.01% 1114
2014
Q3
Sell
-120,000
Closed -$1.19M 971
2014
Q2
$1.19M Buy
+120,000
New +$1.06M 0.04% 512

Other funds holding DXCM

Zurich Cantonal Bank's DXCM Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its DexCom (DXCM) stake by 7.6% in Q2 2026, selling an estimated $806K and leaving 147,227 shares worth $9.92M. The position accounts for 0.02% of the portfolio, ranked #496.

Zurich Cantonal Bank first reported a position in DXCM in Q2 2014 and has held it in 46 quarters since. The position peaked at $21.5M in Q2 2023. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Zurich Cantonal Bank held 147,227 shares of DexCom worth $9.92M as of Q2 2026.
  • Zurich Cantonal Bank sold 12,092 DexCom shares in Q2 2026, an estimated $806K.
  • DexCom made up 0.02% of Zurich Cantonal Bank's portfolio in Q2 2026, its #496 holding.
  • Zurich Cantonal Bank first reported a position in DexCom in Q2 2014 and has held it in 46 quarters since.
  • Zurich Cantonal Bank's DexCom position peaked at $21.5M in Q2 2023.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.